DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago.
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
US FTC probing DaVita, Fresenius Medical, Politico reports
The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.
Here's Why You Should Add DaVita (DVA) to Your Portfolio
DaVita's (DVA) strength in its kidney care raises optimism about the stock.
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth Knowing
DaVita HealthCare (DVA) concluded the recent trading session at $137.92, signifying a +0.39% move from its prior day's close.
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
